Prognostic value of cystatin С in pulmonary embolism
- 9 March 2026
- journal article
- Published by Non-profit organization Nephrology in Nephrology (Saint-Petersburg)
- Vol. 30 (1) , 72-80
Abstract
BACKGROUND. Standard criteria allow diagnosing AKI within hours to days. The use of biomarkers is a promising approach for early diagnosis and prognosis of AKI. THE AIM: to study the capabilities of serum cystatin C (CYS) in the early diagnosis and prognosis of AKI and associated hospital mortality, the risk of 30-day death in pulmonary embolism (PE). PATIENTS (MATERILS) AND METHODS. 98 patients with suspected PE were included; patients were excluded if the diagnosis was not confirmed. CYS was determined on admission, the difference between the determined CYS and the estimated CYS corresponding to a glomerular filtration rate (GFR) of 75 ml/min/1.73 m2 (CYSdiff) and the difference between the GFR by CYS and the GFR by creatinine (eGFRdiff) were calculated. RESULTS. AKI was diagnosed in 13 of 63 patients with PE (men – 36(57 %), age – 67(12) years). In 7(54 %) cases, AKI was detected against the background of chronic kidney disease (CKD), in 6(46 %) – first-onset AKI. CYS>2.55 μg/ ml predicted AKI (sensitivity – 70 %, specificity – 62 %; AUC=0,70; p=0,01) and AKI in CKD patients (sensitivity – 86 %, specificity – 62 %; AUC=0,78; p=0,001). CYSdiff>1,62 μg/ml predicted AKI (sensitivity – 69 %, specificity – 68 %; AUC=0,70; p=0,01). 5 patients (9 %) died in hospital. Mortality was higher in AKI (χ2 =5.8; p=0,02). CYS, CYSdiff did not predict hospital mortality, while CYS>2,17 μg/ml (sensitivity – 70 %, specificity – 70 %; AUC=0,76; p=0,0001) and CYSdiff>1,22 μg/ml (sensitivity – 70 %, specificity – 70 %; AUC=0.77; p0,05). CONCLUSION. The results of the study confirm the effectiveness of CYS in the early diagnosis and prediction of AKI, including cases associated with CKD. The accuracy of prediction can be improved using CYSdiff. CYS does not predict in-hospital mortality but is associated with a high risk of 30-day death in PE.Keywords
This publication has 27 references indexed in Scilit:
- Evaluation of neutrophil gelatinase-associated lipocalin (NGAL), hypoxia-induced factor-1 alpha (HIF-1α) and apelin 13 levels as new potential biomarkers for pulmonary thromboembolism: A prospective clinical studyRespiratory Medicine, 2024
- KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney DiseaseKidney International, 2024
- Management of oliguriaIntensive Care Medicine, 2022
- Age-Adjusted Mortality Rates and Age and Risk–Associated Contributions to Change in Heart Disease and Stroke Mortality, 2011-2019 and 2019-2020JAMA Network Open, 2022
- The difference between cystatin C- and creatinine-based eGFR is associated with adverse cardiovascular outcome in patients with chronic kidney diseaseAtherosclerosis, 2021
- Recommendations on Acute Kidney Injury Biomarkers From the Acute Disease Quality Initiative Consensus ConferenceJAMA Network Open, 2020
- Creatinine: From physiology to clinical applicationEuropean Journal of Internal Medicine, 2020
- Frequency and prognostic impact of acute kidney injury in patients with acute pulmonary embolism. Data from the RIETE registryInternational Journal of Cardiology, 2019
- Effect of Early vs Delayed Initiation of Renal Replacement Therapy on Mortality in Critically Ill Patients With Acute Kidney InjuryJAMA, 2016
- Estimating GFR Using the CKD Epidemiology Collaboration (CKD-EPI) Creatinine Equation: More Accurate GFR Estimates, Lower CKD Prevalence Estimates, and Better Risk PredictionsAmerican Journal of Kidney Diseases, 2010